Galectin Therapeutics Still A Favorite Pick Of H.C. Wainwright Analysts
September 28, 2015 at 14:11 PM EDT
H.C. Wainwright reiterated a Buy rating and $7.00 price target on shares of Galectin Therapeutics Inc (NASDAQ: GALT) on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.